TAYS Sydaenkeskus Oy — Clinical Trial Site

10 Registered trials

6 Currently recruiting

Organisation

TAYS Sydaenkeskus Oy

Location

Tampere, Finland

Identifier

ORG-100046345

Address

Teiskontie 35, 33520, Finland

Departments

Cardiology
Department Heart Center, TAYS Sydänkeskus Oy, P. O. Box 2000, 33521 Tampere
Dept. of urology
Heart Hospital
Hematology dept.
Interventional cardiology
NA
Pediatrics, Dept of Hematology and Oncology
Sydänsairaala

Clinical trials at this site (10)

Search interface

Antibiotic Treatment Trial in Acute Coronary Syndrome Pending

2025-522136-14-00 non-ST-elevation myocardial infarction (NSTEMI), ST-ele 11
Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting

2022-502503-30-00 Acute lymphoblastic leukemia 5 2022-12-15
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
A study to evaluate the efficacy of APG-2575 (Lisaftoclax) plus azacitidine (AZA) vs. placebo plus AZA in newly diagnosed adult subjects wit… Recruiting

2024-517247-31-00 Newly Diagnosed Higher Risk Myelodysplastic Syndrome 5 2025-07-07
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE) Recruiting

2023-504340-34-01 Coronary artery disease 6 2024-01-11
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
A study to compare the study treatment darolutamide in combination with androgen deprivation therapy (ADT) to placebo in combination with AD… Ended

2022-501343-33-00 Biochemically recurrent prostate cancer 5 2023-10-18
Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in pati… Ended

2023-508551-40-00 Coronary artery multi-vessel disease and left main sten 6 2018-06-08
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24